The medical center needs to raise $500,000 by the end of this week to pay off overdue health benefits costs, the CEO said, in today's bite-sized hospital and health industry news from Massachusetts, Oklahoma, and South Carolina.
When a drugmaker seeks approval for a new drug from FDA, it must prove that its medication is safe and effective—but it doesn't have to answer an equally critical question: Is the drug more effective than other ways of treating the same condition? Writing for the New York Times' "The Upshot," Aaron Carroll explains why such a simple, practical question so often goes unexplored in medicine.
A Wall Street Journal analysis shows that dozens of contracts between hospitals and insurers include secret, restrictive terms such as "anti-steering" clauses that limit insurers' ability to design low-cost health plans for major employers, such as Walmart and Home Depot.
For the survey, Medscape asked 11,549 physicians about the factors important to them when selecting a hospital for treatment for themselves or a loved one, as well as the hospital they would select for themselves or a family member for 10 conditions and procedures.
At a time in medicine where physicians, hospitals, and reporters are routinely touting the lifesaving aspects of medical advances, such as precision medicine, one doctor stands out: taking to Twitter and physician conferences to bombastically counter what he calls "hype" in medicine, Richard Harris reports for NPR's "Shots."
Print All Daily Briefing Article from
Have a Question?
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.